The efficacy and safety of vincristine, irinotecan and anlotinib in Epithelioid Sarcoma
Abstract Background Epithelioid sarcoma is a rare soft tissue sarcoma characterized by SMARCB1/INI1 deficiency. Much attention has been paid to the selective EZH2 inhibitor tazemetostat, where other systemic treatments are generally ignored. To explore alternative treatment options, we studied the e...
Tallennettuna:
| Päätekijät: | , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMC
2024-02-01
|
| Sarja: | BMC Cancer |
| Aiheet: | |
| Linkit: | https://doi.org/10.1186/s12885-024-11921-7 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|